- The Modified Melphalan-Cladribine- Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo- HSCT in Refractory/Relapsed AMLZhang, Xiaoyu; Chen, Shulian; Zhai, Weihua; He, Yi; Feng, Sizhou; Han, Mingzhe; Niu, Ting; Xu, Yajing; Gao, Guangxun; Fan, Shengjin; Zhou, Zepin; Zhou, Fang; Xi, Rui; Liu, Li; Yang, Wei; Zhang, Xi; Liu, Qifa; Jiang, Erlie65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationXuan, Li; Dai, Min; Jiang, Erlie; Wang, Yu; Huang, Fen; Fan, Zhiping; Xu, Na; Nie, Danian; Liang, Xinquan; Chen, Hong; Ye, Jieyu; Shi, Pengcheng; Liu, Hui; Jin, Hua; Lin, Ren; Yan, Chenhua; Zhang, Yu; Sun, Jing; Han, Mingzhe; Liu, Qifa64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-CenterWu, Ping; Ling, Wei; Luo, Chengwei; Chen, Xiaomei; Huang, Lisi; Wang, Jinghua; Lai, Peilong; Wu, Suijing; Du, Xin; Weng, Jianyu65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML Patients
9阅读
